Health Catalyst, Inc. (NASDAQ:HCAT) Receives $3.16 Average Target Price from Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have received an average recommendation of “Hold” from the thirteen research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $3.1591.

HCAT has been the topic of several recent research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Health Catalyst in a research note on Monday, December 29th. Cantor Fitzgerald cut their target price on shares of Health Catalyst from $4.00 to $3.00 and set a “neutral” rating for the company in a research note on Friday. Citigroup reduced their target price on shares of Health Catalyst from $2.75 to $1.75 and set a “neutral” rating for the company in a report on Friday, March 13th. Stephens decreased their price target on shares of Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating on the stock in a research report on Friday, March 13th. Finally, Canaccord Genuity Group dropped their price target on Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a report on Friday.

Institutional Investors Weigh In On Health Catalyst

Institutional investors and hedge funds have recently modified their holdings of the stock. First Light Asset Management LLC boosted its position in shares of Health Catalyst by 9.9% in the 3rd quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company’s stock valued at $38,293,000 after purchasing an additional 1,206,039 shares during the period. Vanguard Group Inc. raised its holdings in Health Catalyst by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock worth $12,243,000 after buying an additional 119,117 shares during the period. Whetstone Capital Advisors LLC raised its holdings in Health Catalyst by 0.5% during the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock worth $8,963,000 after buying an additional 19,027 shares during the period. Nepsis Inc. lifted its stake in Health Catalyst by 26.6% during the fourth quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock valued at $4,579,000 after buying an additional 402,762 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Health Catalyst by 11.4% during the second quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after buying an additional 169,580 shares in the last quarter. 85.00% of the stock is owned by institutional investors and hedge funds.

Health Catalyst Trading Down 3.7%

Shares of Health Catalyst stock opened at $1.17 on Friday. The business has a fifty day simple moving average of $2.01 and a 200-day simple moving average of $2.52. Health Catalyst has a fifty-two week low of $1.16 and a fifty-two week high of $5.06. The firm has a market cap of $86.10 million, a price-to-earnings ratio of -0.46 and a beta of 1.77. The company has a quick ratio of 1.89, a current ratio of 1.89 and a debt-to-equity ratio of 0.62.

Health Catalyst (NASDAQ:HCAT) last released its earnings results on Thursday, March 12th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). Health Catalyst had a negative return on equity of 4.30% and a negative net margin of 57.20%.The firm had revenue of $74.68 million for the quarter, compared to analyst estimates of $73.99 million. On average, equities analysts forecast that Health Catalyst will post -0.33 EPS for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.